Clinical Trial Update: Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating adefovir plus vaccination in liver transplant recipients without Hepatitis B who are core antibody positive; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Transplantation

Drugs mentioned

• Adefovir (adefovir)

Snippet

Sponsor: Columbia University | Conditions: Hepatitis B, Liver Transplantation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-03-15